Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Bellerophon Therapeutics Inc (BLPH)  
$0.28 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 6,130,000
Market Cap: 1.71(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2787 - $0.2787
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Bellerophon Therapeutics is a clinical-stage therapeutics company focused on developing products that address unmet medical needs in the treatment of cardiopulmonary diseases. Co.'s focus is the continued development of its nitric oxide therapy for patients with or at risk of pulmonary hypertension, or PH, using its proprietary pulsatile nitric oxide delivery platform, INOpulse. Co.'s INOpulse program is an extension of the technology used in hospitals to deliver continuous-flow inhaled nitric oxide. Co. is developing its INOpulse for the treatment of patients with fibrotic interstitial lung disease at a risk for pulmonary hypertension.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 1,211,262 1,780,717
Total Sell Value $0 $0 $223,345 $5,615,495
Total People Sold 0 0 1 3
Total Sell Transactions 0 0 2 4
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 188
  Page 8 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Naidu Manesh Chief Business OfficerOfficer   •       –      –    2015-02-13 3 IO $0.00 $0 D/D 0 8,402     -
   Naidu Manesh Chief Business OfficerOfficer   •       –      –    2015-02-13 3 IO $0.00 $0 D/D 0 1,417     -
   Luehring Jens Director   –       •       •   2015-02-13 3 IO $0.00 $0 I/I 0 1,270,888     -
   Bybee Clinton 10% Owner   –       –       •   2015-02-13 3 IO $0.00 $0 D/D 0 752,994     -
   Holt Matthew S. Director   –       •       •   2015-02-13 3 IO $0.00 $0 I/I 0 3,789,719     -
   Nelsen Robert Director   –       •       •   2015-02-13 3 IO $0.00 $0 I/I 0 752,994     -
   Peacock Jonathan M President and CEOOfficer   •       •      –    2015-02-13 3 IO $0.00 $0 D/D 0 67     -
   Weinstein Adam Director   –       •       •   2015-02-12 4 A $0.00 $0 I/I 460,144 3,789,719     -
   Weinstein Adam Director   –       •       •   2015-02-12 4 D $0.00 $0 I/I (460,144) 3,329,575     -
   Nelsen Robert Director   –       •       •   2015-02-12 4 A $0.00 $0 I/I 752,994 752,994     -
   Nelsen Robert Director   –       •       •   2015-02-12 4 D $0.00 $0 I/I (752,994) 0     -
   Holt Matthew S. Director   –       •       •   2015-02-12 4 A $0.00 $0 I/I 460,144 3,789,719     -
   Holt Matthew S. Director   –       •       •   2015-02-12 4 D $0.00 $0 I/I (460,144) 3,329,575     -

  188 Records found
  1  2  3  4  5  6  7  8    
  Page 8 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed